Inhibition of ACC in tumor microenvironment can enhance mitochondrial use of free fatty acids and bioenergetics, improving CD8+ T cell survival and antitumor effects in tumor microenvironment (Hunt et al., 2024). This evidence concerns the gene CD8A and neoplasm.